NCT00105144

Brief Summary

The purpose of the study is to determine the safety and effectiveness of two dose levels of micafungin versus caspofungin in the treatment of proven invasive candidiasis or candidemia.

Trial Health

98
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Strong global presence with extensive site network
Enrollment
611

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Sep 2004

Geographic Reach
15 countries

167 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2004

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 7, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 8, 2005

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2006

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2006

Completed
Last Updated

September 18, 2014

Status Verified

September 1, 2014

Enrollment Period

1.6 years

First QC Date

March 7, 2005

Last Update Submit

September 17, 2014

Conditions

Keywords

Treatment EffectivenessTreatment EfficacyInvestigational, TherapiesAntifungal, SystemicAntibiotics, AntifungalMicafungin

Outcome Measures

Primary Outcomes (1)

  • Overall treatment success, based on the investigator's assessment of pre-defined clinical and mycological response at the End of intravenous (IV) Therapy

    End of therapy and 6 weeks post-treatment

Secondary Outcomes (1)

  • Overall treatment success, based on the Data Review Panel's assessment of pre-defined clinical and mycological response at the End of IV Therapy

    End of therapy and 6 weeks post-treatment

Study Arms (3)

1

EXPERIMENTAL

lower dose

Drug: Micafungin

2

EXPERIMENTAL

higher dose

Drug: Micafungin

3

ACTIVE COMPARATOR
Drug: Caspofungin

Interventions

IV

Also known as: Mycamine, FK463
12

IV

Also known as: Cancidas
3

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients must have candidemia or invasive candidiasis.

You may not qualify if:

  • Patients who have received an echinocandin within one month prior to study entry.
  • Patients who have received more than two days of prior systemic antifungal therapy for the current infection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (167)

Unknown Facility

Birmingham, Alabama, 35294, United States

Location

Unknown Facility

Little Rock, Arkansas, 72205, United States

Location

Unknown Facility

Los Angeles, California, 90033, United States

Location

Unknown Facility

Los Angeles, California, 90095, United States

Location

Unknown Facility

San Francisco, California, 94115, United States

Location

Unknown Facility

Denver, Colorado, 80204, United States

Location

Unknown Facility

Denver, Colorado, 80262, United States

Location

Unknown Facility

Washington D.C., District of Columbia, 20010, United States

Location

Unknown Facility

Bay Pines, Florida, 33744, United States

Location

Unknown Facility

Miami, Florida, 33136, United States

Location

Unknown Facility

Atlanta, Georgia, 30322, United States

Location

Unknown Facility

Augusta, Georgia, 30909, United States

Location

Unknown Facility

Augusta, Georgia, 30912, United States

Location

Unknown Facility

Chicago, Illinois, 60612, United States

Location

Unknown Facility

Chicago, Illinois, 60637, United States

Location

Unknown Facility

Maywood, Illinois, 60153, United States

Location

Unknown Facility

Beech Grove, Indiana, 46107, United States

Location

Unknown Facility

Evansville, Indiana, 47714, United States

Location

Unknown Facility

Des Moines, Iowa, 50309, United States

Location

Unknown Facility

Iowa City, Iowa, 52242, United States

Location

Unknown Facility

Kansas City, Kansas, 66160, United States

Location

Unknown Facility

Wichita, Kansas, 67214, United States

Location

Unknown Facility

Lexington, Kentucky, 40536, United States

Location

Unknown Facility

New Orleans, Louisiana, 70121, United States

Location

Unknown Facility

Baltimore, Maryland, 21201, United States

Location

Unknown Facility

Baltimore, Maryland, 21287, United States

Location

Unknown Facility

Boston, Massachusetts, 02111, United States

Location

Unknown Facility

Boston, Massachusetts, 02115, United States

Location

Unknown Facility

Boston, Massachusetts, 02215, United States

Location

Unknown Facility

Detroit, Michigan, 48201, United States

Location

Unknown Facility

Detroit, Michigan, 48202, United States

Location

Unknown Facility

Minneapolis, Minnesota, 55455, United States

Location

Unknown Facility

Jackson, Mississippi, 39216, United States

Location

Unknown Facility

St Louis, Missouri, 63310, United States

Location

Unknown Facility

Neptune City, New Jersey, 07754, United States

Location

Unknown Facility

Albany, New York, 12208, United States

Location

Unknown Facility

Manhasset, New York, 11030, United States

Location

Unknown Facility

New Hyde Park, New York, 11040, United States

Location

Unknown Facility

New York, New York, 10029, United States

Location

Unknown Facility

New York, New York, 10032, United States

Location

Unknown Facility

Rochester, New York, 14642, United States

Location

Unknown Facility

Stony Brook, New York, 11794, United States

Location

Unknown Facility

The Bronx, New York, 10467, United States

Location

Unknown Facility

Valhalla, New York, 10595, United States

Location

Unknown Facility

Durham, North Carolina, 27710, United States

Location

Unknown Facility

Winston-Salem, North Carolina, 27157, United States

Location

Unknown Facility

Cincinnati, Ohio, 45267, United States

Location

Unknown Facility

Columbus, Ohio, 43210, United States

Location

Unknown Facility

Allentown, Pennsylvania, 18103, United States

Location

Unknown Facility

Philadelphia, Pennsylvania, 19104, United States

Location

Unknown Facility

Philadelphia, Pennsylvania, 19140, United States

Location

Unknown Facility

Pittsburgh, Pennsylvania, 15213, United States

Location

Unknown Facility

West Reading, Pennsylvania, 19611, United States

Location

Unknown Facility

Providence, Rhode Island, 02908, United States

Location

Unknown Facility

Jackson, Tennessee, 38301, United States

Location

Unknown Facility

Memphis, Tennessee, 38104, United States

Location

Unknown Facility

Dallas, Texas, 75246, United States

Location

Unknown Facility

Houston, Texas, 77030, United States

Location

Unknown Facility

San Antonio, Texas, 78229, United States

Location

Unknown Facility

Charlottesville, Virginia, 22908, United States

Location

Unknown Facility

Fairfax, Virginia, 22030, United States

Location

Unknown Facility

Seattle, Washington, 98109, United States

Location

Unknown Facility

Vienna, 1090, Austria

Location

Unknown Facility

Aalst, 9300, Belgium

Location

Unknown Facility

Brussels, 1000, Belgium

Location

Unknown Facility

Brussels, 1070, Belgium

Location

Unknown Facility

Brussels, 1090, Belgium

Location

Unknown Facility

Brussels, 1200, Belgium

Location

Unknown Facility

Ghent, 9000, Belgium

Location

Unknown Facility

Liège, 4800, Belgium

Location

Unknown Facility

Belo Horizonte, Mg-cep, 30140-093, Brazil

Location

Unknown Facility

Belo Horizonte, Mg-cep, 30190-081, Brazil

Location

Unknown Facility

Belo Horizonte, Minas Gerais, 30190-081, Brazil

Location

Unknown Facility

Cunitiba, Pr-cep, 80060-900, Brazil

Location

Unknown Facility

Rio de Janeiro, Rio de Janeiro, 21941-590, Brazil

Location

Unknown Facility

Porto Alegre, Rio Grande do Sul, Brazil

Location

Unknown Facility

Santos, SĂ£o Paulo, 11045-904, Brazil

Location

Unknown Facility

SĂ£o JosĂ© do Rio Preto, SĂ£o Paulo, 15090-000, Brazil

Location

Unknown Facility

SĂ£o Paulo, SĂ£o Paulo, 04039-020, Brazil

Location

Unknown Facility

Belo Horizonte, 30110-908, Brazil

Location

Unknown Facility

Belo Horizonte, 30130-110, Brazil

Location

Unknown Facility

Belo Horizonte, 30190-130, Brazil

Location

Unknown Facility

Salvador, 40050-410, Brazil

Location

Unknown Facility

Salvador, 40110-160, Brazil

Location

Unknown Facility

SĂ£o Paulo, 01500-000, Brazil

Location

Unknown Facility

SĂ£o Paulo, 04012-180, Brazil

Location

Unknown Facility

SĂ£o Paulo, 04040-002, Brazil

Location

Unknown Facility

Edmonton, Alberta, T6G 2B7, Canada

Location

Unknown Facility

Kelowna, British Columbia, V1Y 1T2, Canada

Location

Unknown Facility

Winnipeg, Manitoba, R3A 1R9, Canada

Location

Unknown Facility

St. John's, Newfoundland and Labrador, A1B 3V6, Canada

Location

Unknown Facility

Halifax, Nova Scotia, B3H 1V7, Canada

Location

Unknown Facility

Hamilton, Ontario, L8V 1C3, Canada

Location

Unknown Facility

Kingston, Ontario, K7L 2V7, Canada

Location

Unknown Facility

Ottawa, Ontario, K1H 8L6, Canada

Location

Unknown Facility

Toronto, Ontario, M5G 2N2, Canada

Location

Unknown Facility

Chicoutimi, Quebec, G7H 5H6, Canada

Location

Unknown Facility

Greenfield Park, Quebec, J4V 2H1, Canada

Location

Unknown Facility

Montreal, Quebec, H1T 2M4, Canada

Location

Unknown Facility

Montreal, Quebec, H2X 2P4, Canada

Location

Unknown Facility

Québec, Quebec, G1R 2J6, Canada

Location

Unknown Facility

Regina, Saskatchewan, S4P 0W5, Canada

Location

Unknown Facility

Saskatoon, Saskatchewan, S7N 0W8, Canada

Location

Unknown Facility

Zagreb, 10000, Croatia

Location

Unknown Facility

Prague, 14021, Czechia

Location

Unknown Facility

Bobigny, 93009, France

Location

Unknown Facility

Metz, 57000, France

Location

Unknown Facility

Paris, 75181, France

Location

Unknown Facility

Paris, 75651, France

Location

Unknown Facility

Paris, 75674, France

Location

Unknown Facility

Paris, 75877, France

Location

Unknown Facility

Strasbourg, 67098, France

Location

Unknown Facility

Villejuif, 94084, France

Location

Unknown Facility

Villejuif, 94805, France

Location

Unknown Facility

Berlin, 10117, Germany

Location

Unknown Facility

Bielefeld, 33611, Germany

Location

Unknown Facility

Cologne, 50937, Germany

Location

Unknown Facility

Frankfurt, 60590, Germany

Location

Unknown Facility

Hanover, 30625, Germany

Location

Unknown Facility

Ulm, 89081, Germany

Location

Unknown Facility

WĂ¼rzburg, 97070, Germany

Location

Unknown Facility

Bangalore, 560017, India

Location

Unknown Facility

Bangalore, 56017, India

Location

Unknown Facility

Bangalore, India

Location

Unknown Facility

Banglore, 560 054, India

Location

Unknown Facility

Chandigarh, India

Location

Unknown Facility

Chennai, 35, India

Location

Unknown Facility

Chennai, 600 006, India

Location

Unknown Facility

Cochin Kerala, 682 026, India

Location

Unknown Facility

Hyderabad, 500 009, India

Location

Unknown Facility

Hyderabad, 500 033, India

Location

Unknown Facility

Hyderabad, 500 034, India

Location

Unknown Facility

Hyderabad, 500 082, India

Location

Unknown Facility

Kochi, India

Location

Unknown Facility

Kolkotta, 700 029, India

Location

Unknown Facility

Lucknow, 226 014, India

Location

Unknown Facility

Ludhiana, 141 009, India

Location

Unknown Facility

Mangalore, 575 001, India

Location

Unknown Facility

Manipal, 576 104, India

Location

Unknown Facility

Mumbai, 400 012, India

Location

Unknown Facility

Mumbai, 400 026, India

Location

Unknown Facility

Uttar Pradesh, 201 301, India

Location

Unknown Facility

Groningen, 9700 RB, Netherlands

Location

Unknown Facility

Gdansk, 80-211, Poland

Location

Unknown Facility

Lodz, 93-513, Poland

Location

Unknown Facility

Warsaw, 00-957, Poland

Location

Unknown Facility

Barakaldo, 48903, Spain

Location

Unknown Facility

Barcelona, 08003, Spain

Location

Unknown Facility

Barcelona, 08025, Spain

Location

Unknown Facility

Barcelona, 08035, Spain

Location

Unknown Facility

Barcelona, 08036, Spain

Location

Unknown Facility

Madrid, 28005, Spain

Location

Unknown Facility

Madrid, 28007, Spain

Location

Unknown Facility

Madrid, 28034, Spain

Location

Unknown Facility

Madrid, 28041, Spain

Location

Unknown Facility

Salamanca, 37007, Spain

Location

Unknown Facility

Santander, 39008, Spain

Location

Unknown Facility

Seville, 41014, Spain

Location

Unknown Facility

Valencia, 46009, Spain

Location

Unknown Facility

Sankt Gallen, 9007, Switzerland

Location

Unknown Facility

London, England, SE1 7EH, United Kingdom

Location

Unknown Facility

London, England, SW10 9NH, United Kingdom

Location

Unknown Facility

London, England, W6 8RF, United Kingdom

Location

Unknown Facility

Manchester, England, M23 9LT, United Kingdom

Location

Unknown Facility

Glasgow, GB, G11 6NT, United Kingdom

Location

Unknown Facility

Leeds, GB, LS1 3EX, United Kingdom

Location

Unknown Facility

Leeds, GB, LS9 7TF, United Kingdom

Location

Related Publications (2)

  • Pappas PG, Rotstein CM, Betts RF, Nucci M, Talwar D, De Waele JJ, Vazquez JA, Dupont BF, Horn DL, Ostrosky-Zeichner L, Reboli AC, Suh B, Digumarti R, Wu C, Kovanda LL, Arnold LJ, Buell DN. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis. 2007 Oct 1;45(7):883-93. doi: 10.1086/520980. Epub 2007 Aug 29.

    PMID: 17806055BACKGROUND
  • Shorr AF, Wu C, Kothari S. Outcomes with micafungin in patients with candidaemia or invasive candidiasis due to Candida glabrata and Candida krusei. J Antimicrob Chemother. 2011 Feb;66(2):375-80. doi: 10.1093/jac/dkq446. Epub 2010 Dec 8.

MeSH Terms

Conditions

CandidiasisCandidemia

Interventions

MicafunginCaspofungin

Condition Hierarchy (Ancestors)

MycosesBacterial Infections and MycosesInfectionsCandidiasis, InvasiveInvasive Fungal InfectionsFungemiaSepsisSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

LipopeptidesLipidsPeptidesAmino Acids, Peptides, and ProteinsEchinocandinsPeptides, Cyclic

Study Officials

  • Central Contact

    Astellas Pharma US, Inc.

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 7, 2005

First Posted

March 8, 2005

Study Start

September 1, 2004

Primary Completion

April 1, 2006

Study Completion

April 1, 2006

Last Updated

September 18, 2014

Record last verified: 2014-09

Locations